Wells Fargo’s Spruce Biosciences, Inc. Common Stock SPRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-143
| Closed | -$112 | – | 7078 |
|
|
2024
Q1 | $112 | Buy |
143
+2
| +1% | +$2 | ﹤0.01% | 6235 |
|
|
2023
Q4 | $413 | Buy |
141
+11
| +8% | +$32 | ﹤0.01% | 5987 |
|
|
2023
Q3 | $294 | Sell |
130
-56
| -30% | -$127 | ﹤0.01% | 6110 |
|
|
2023
Q2 | $400 | Buy |
186
+119
| +178% | +$256 | ﹤0.01% | 6227 |
|
|
2023
Q1 | $148 | Sell |
67
-399
| -86% | -$881 | ﹤0.01% | 6524 |
|
|
2022
Q4 | $511 | Sell |
466
-198
| -30% | -$217 | ﹤0.01% | 6050 |
|
|
2022
Q3 | $1K | Sell |
664
-395
| -37% | -$595 | ﹤0.01% | 6165 |
|
|
2022
Q2 | $2K | Sell |
1,059
-3,793
| -78% | -$7.16K | ﹤0.01% | 6096 |
|
|
2022
Q1 | $10K | Sell |
4,852
-4,623
| -49% | -$9.53K | ﹤0.01% | 5922 |
|
|
2021
Q4 | $43K | Sell |
9,475
-1,444
| -13% | -$6.55K | ﹤0.01% | 5576 |
|
|
2021
Q3 | $66K | Buy |
10,919
+3,885
| +55% | +$23.5K | ﹤0.01% | 5231 |
|
|
2021
Q2 | $79K | Buy |
7,034
+4,860
| +224% | +$54.6K | ﹤0.01% | 5078 |
|
|
2021
Q1 | $36K | Sell |
2,174
-1,550
| -42% | -$25.7K | ﹤0.01% | 5611 |
|
|
2020
Q4 | $90K | Buy |
+3,724
| New | +$90K | ﹤0.01% | 5231 |
|